• Profile

Clinical factors associated with urinary tract cancer in individuals with Lynch syndrome

Cancer Epidemiology, Biomarkers & Prevention Dec 08, 2019

Wischhusen JW, et al. - In a cohort including 52,758 consecutively determined people undergoing Lynch syndrome testing at a commercial laboratory, researchers explored clinical factors related to urinary tract cancers (UTC; renal pelvis, ureter, bladder, and possibly kidney cancers) among Lynch syndrome carriers, by performing univariate analysis and multivariate logistic regression. The probability of having had UTC was found to be significantly more in Lynch syndrome carriers vs noncarriers. They observed the independent link of Lynch syndrome–related UTC with male gender, increased age, familial burden of UTC, and pathogenic EPCAM/MSH2 variants but not MLH1 variants, race, or history of other Lynch syndrome–associated malignancy. They noted the presence of ≥ 1 of the following features: male gender, EPCAM/MSH2 variants, or family history of UTC in 143 of 158 (90.5%) Lynch syndrome carriers with UTC; 1,236 of 1,251 (98.8%) Lynch syndrome carriers lacking all of these features had no history of UTC. Experts concluded that the recognition of Lynch syndrome carriers who are most likely to be at risk for UTC can reliably be done by taking specific clinical factors into account.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
M3 app logo
Choose easy access to M3 India from your mobile!

M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen